Home Healthcare IT Antitumor Antibiotics Market Trends, Growth, & Share-2031

Antitumor Antibiotics Market

Antitumor Antibiotics Market: Information by Drug Type (Anthracyclines, Chromomycins, Miscellaneous), Distribution Channel (Hospital, Retail Pharmacies, Online), Regional —Forecast Till 2031

Global antitumor antibiotic market size accounted for around USD 3,000 million in 2017 and is expected to grow at a CAGR of 5.3% during the forecast period, (2019–2026).  Antitumor antibiotic drugs are used in che
Report Code: SRHI222DR

Market Overview

Global antitumor antibiotic market size accounted for around USD 3,000 million in 2017 and is expected to grow at a CAGR of 5.3% during the forecast period, (2019–2026). 

Antitumor antibiotic drugs are used in chemotherapy to treatment different types of cancers such as leukemia, bladder cancer, and others. In every three minutes a person is diagnosed with leukemia in the U.S and it is also one of the most common cancers among children. Around 437,033 new cases of leukemia were diagnosed in 2018 worldwide, the American Institute for Cancer research. Today, the market is packed with a wide range of chemotherapy drugs, let it be single drug or combination of drugs.  Anthracyclines is one of the leading types of antitumor antibiotic drugs and has been effectively used for treating leukemia, ovarian, breast, stomach, and other cancer therapies. Anthracyclines are also used in breast cancer treatment. Over 13 million electronic medical records exist in the U.S. for cancer patients.

Report Scope

Report Metric Details
Base Year 2022
Study Period 2021-2031
Forecast Period 2023-2031
CAGR 5.3%
Market Size USD 3,000 million in 2017
Fastest Growing Market Asia Pacific
Largest Market Europe
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Geographies Covered
  • North America
  • Europe
  • APAC
  • Middle East and Africa
Get more information on this report Download Sample Report

Regional Analysis

Geographically, the global antitumor antibiotic market is segmented into four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa (MEA).

From the past few years, the overall prevalence of cancer has grown exponentially across the Americas. Currently, the region is burdened with high demand for effective drugs to treat this disease. In a study, it has been found that the prevalence of cancer is higher among older patients in the U.S. For instance, around 87% of cancers are diagnosed in the people above 50 years. This has again increased the economic burden on the country. In 2015, the direct medical cost for cancer treatment was accounted for around USD 80.2 billion in the U.S.  So far, numerous drugs have been introduced to the market and many more are in pipeline. For instance, 14 new active substances for cancer therapeutics were launched in 2017 and 11 of them were categorized under breakthrough therapy by the Food and Drugs Administration.

Asia Pacific is expected to witness significant growth during the forecast period. The region has large cancer population. Prevalence of breast cancer in Asia is much higher than western countries, which is mainly attributed to rapid lifestyle changes, especially fertility pattern. In addition, lack of awareness is another prominent concern in the region. Apart from this, some well-educated countries such as South Korea and Japan have stigmatized the breast cancer issue leading to high untreated population. To tackle this crucial situation, policymakers need to follow a comprehensive plan, which include screening, affordable drugs, and better healthcare policies. Governments in the region are focused on providing sustainable treatment. For instance, India has 27 region cancer centers, and the government provides up to 50,000 financial support to poor patients. China has reduced import tariff on major cancer drugs, including 39 patented drugs to reduce the prices of these drugs. Moreover, Japan has simplified the average development times and the regulatory approval process for new molecules to encourage better treatment alternatives.

Regional Growth Insights Download Free Sample

Segmental Analysis

Global antitumor antibiotic market is segmented by drug type and distribution channel.

By drug type, the market is segmented into anthracyclines, chromomycins, and miscellaneous. Anthracyclines is projected to witness huge demand in the coming years on account of growing prevalence of leukemia and bladder cancers. Moreover, its use in combination therapy has shown promising results during treatment. Anthracycline in chemo regime has shown better results than without anthracycline chemotherapy. As per study conducted on 4,130 women suffering from breast cancer for anthracyclines therapy showed that women lived longer without reassurance of cancer.

By distribution channel, the antitumor antibiotic market is segmented into hospitals, retail pharmacies, and online. Hospitals are holding the major grip on market, which be a result of easy availability of drugs and large patient population visiting hospitals.

Top Key Players of Antitumor Antibiotics Market

  1. Astellas Pharma Inc. (Japan)
  2. Johnson & Johnson Services Inc. (U.S.)
  3. Bristol-Myers Squibb Company (U.S.)
  4. Novartis AG (Switzerland)
  5. Pfizer Inc. (U.S.)
  6. Merck & Co. Inc. (U.S.)
  7. AG Scientific (U.S.)
  8. Amgen Inc. (U.S.).

Antitumor Antibiotics Market Segmentations

By Drug Type

  • Anthracyclines
    • Daunorubicin
    • Doxorubicin
    • Idarubicin
    • Epirubicin
  • Chromomycins
    • Dactinomycin
    • Plicamycin
  • Miscellaneous
    • Mitomycin
    • Bleomycin

By Distribution Channel

  • Hospitals
  • Retail Pharmacies
  • Online

By Regions

  • North America
  • Europe
  • APAC
  • Middle East and Africa

Frequently Asked Questions (FAQs)

What is the estimated growth rate (CAGR) of the Antitumor Antibiotics Market?
Antitumor Antibiotics Market size will grow at approx. CAGR of 5.3% during the forecast period.
Some of the top prominent players in Antitumor Antibiotics Market are, Astellas Pharma Inc. (Japan), Johnson & Johnson Services Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Merck & Co. Inc. (U.S.), AG Scientific (U.S.), Amgen Inc. (U.S.)., etc.
Europe has been dominating the Antitumor Antibiotics Market, accounting for the largest share of the market.
The Asia Pacific region is projected to exhibit the highest rate of growth in the Antitumor Antibiotics Market.
The global Antitumor Antibiotics Market report is segmented as follows: By Drug Type, Distribution Channel

We are featured on :